Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 30 (of 3892 Records) |
Query Trace: Lung Neoplasms and Egfr[original query] |
---|
Clinicopathological significance of sulfite oxidase expression in surgically resected lung adenocarcinoma. Medical molecular morphology 2024 12 . Saeko Tokisawa, Reiichiro Kondo, Masamichi Nakayama, Sachiko Ogasawara, Kenta Murotani, Masahiro Mitsuoka, Tomoaki Hoshino, Hirohisa Yano, Jun Aki |
Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels. PeerJ 2024 12 12 e18618. Jimin Hao, Man Liu, Zhigang Zhou, Chunling Zhao, Liping Dai, Songyun Ouya |
Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer. Chinese medical journal 2024 12 . Xin Dai, Qian Xu, Lei Sheng, Xue Zhang, Miao Huang, Song Li, Kai Huang, Jiahui Chu, Jian Wang, Jisheng Li, Yanguo Liu, Jianyuan Zhou, Shulun Nie, Lian L |
Clinical value of epidermal growth factor receptor mutation testing in peripheral blood of patients with non-small cell lung cancer. Pakistan journal of medical sciences 2024 12 40 (11): 2626-2630. Xiaomeng Zheng, Chengbi Tong, Xiaodong Li, Yanan Meng, Xiaodan L |
Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLC. BMJ open respiratory research 2024 12 11 (1): . Peiling Chen, Xin Zheng, Caichen Li, Jianfu Li, Chen Yang, Yi Feng, Bo Cheng, Hengrui Liang, Zhichao Liu, Yi Zhao, Shan Xiong, Feng Li, Ran Zhong, Shuting Zhan, Huiting Wang, Yang Xiang, Wenhai Fu, Wenjun Ye, Bo'ao Jiang, Xianzhe Fan, Jun Liu, Jianxing He, Wenhua Lia |
Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients With EGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis. Anticancer research 2024 12 44 (12): 5361-5370. Francisco Cezar Aquino DE Moraes, Maria Eduarda Cavalcanti Souza, Emanuele Rocha DA Silva, Michele Kreuz, Rommel Mario Rodriguez Burba |
Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Jii Bum Lee, Su-Jin Choi, Hyo Sup Shim, Byung Jo Park, Chang Young Lee, Sumedha Sudhaman, Sharlene Velichko, Min Hee Hong, Byoung Chul Cho, Sun Min L |
COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancer. The oncologist 2024 12 . Camille Mehlman, Aurelie Swalduz, Isabelle Monnet, Clara Morin, Marie Wislez, Florian Guisier, Hubert Curcio, Pauline Du Rusquec, Alexis B Cortot, Valerie Gounant, Baptiste Abbar, Boris Duchemann, Etienne Giroux-Leprieur, Thomas Pierret, Fleur-Marie Quilot, Jacques Cadranel, Vincent Fall |
Alternating Administration of Osimertinib for Leptomeningitis and Docetaxel Plus Ramucirumab for Lung Adenocarcinoma Resistant to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Case Report. Internal medicine (Tokyo, Japan) 2024 12 . Haruka Tomizawa, Atsuto Mouri, Satsuki Mikoshiba, Kasumi Tsukamoto, Yukiko Abe, Miku Oda, Maya Tsuchiya, Takashi Yamana, Kozo Suhara, Mitsuhiro Kamimu |
Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study. Therapeutic advances in medical oncology 2024 12 16 17588359241303090. Ichidai Tanaka, Kazumi Hori, Junji Koyama, Soei Gen, Masahiro Morise, Yuta Kodama, Akira Matsui, Ayako Miyazawa, Tetsunari Hase, Yoshitaka Hibino, Toshihiko Yokoyama, Tomoki Kimura, Norio Yoshida, Mitsuo Sato, Makoto Ish |
Optimal intervention timing for craniocerebral radiotherapy in EGFR mutant lung adenocarcinoma patients with brain metastases. BMC cancer 2024 12 24 (1): 1571. Guangchuan Deng, Qunxing Zhang, Jing Fan, Chenran Zhao, Hui Jiao, Zhenxiang |
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia (New York, N.Y.) 2024 12 60 101113. Sheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, Chia-Lin Hsu, Ching-Yao Yang, Shang-Gin Wu, Yen-Ting Lin, Yueh-Feng Wen, Lun-Che Chen, Yen-Fu Chen, Ya-Fang Chen, Yen-Heng Lin, Chong-Jen |
The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study. Journal of the Egyptian National Cancer Institute 2024 12 36 (1): 39. Asmaa A Helal, Ibrahim H Kamal, Ahmed Osman, Magdy Youssef, Adel K Ibrah |
Outcomes of patients receiving urgent palliative radiotherapy for advanced lung cancer: an observational study. BMC palliative care 2024 12 23 (1): 296. Yang Xu, Celestee Trach, Tracey Tessier, Rishi Sinha, David Skarsga |
Observational study of the efficacy and safety of first-line osimertinib and later treatments for uncommon epidermal growth factor receptor-activating mutation-positive advanced non-small cell lung cancer. Japanese journal of clinical oncology 2024 12 . Tsuyoshi Hirata, Kageaki Watanabe, Yukio Hosomi, Kiyotaka Yoh, Kazuhiro Usui, Kazuma Kishi, Go Naka, Shu Tamano, Kohei Uemura, Hideo Kunit |
Clinical outcomes of patients with EGFR-mutated NSCLC developing interstitial lung disease during first-line osimertinib therapy: a sub-analysis of the Reiwa study. Japanese journal of clinical oncology 2024 12 . Takayuki Kobayashi, Kageaki Watanabe, Yukio Hosomi, Kiyotaka Yoh, Kazuhiro Usui, Kazuma Kishi, Go Naka, Shu Tamano, Kohei Uemura, Hideo Kunit |
CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma. Genes & genomics 2024 12 . Seongeun Song, Sangmyung Rh |
The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases. Asia-Pacific journal of clinical oncology 2024 12 . Thai Van Pham, Thanh Ha Vu, Hoa Thai Thi Nguyen, Phuong Cam Pham, Anh Tu Do, Tuan Khoi Nguyen, Thi Anh Thu Hoang, Tuan Anh Le, Dinh Thy Hao Vuong, Dac Nhan Tam Nguyen, Van Khiem Dang, Thi Oanh Nguyen, Van Luan Pham, Minh Hai Nguyen, Thi Huyen Trang Vo, Khoa Trong Mai, Hung Kien Do, Thi Thuy Hang Nguyen, Le Huy Trinh, Hoang Gia Nguyen, Cong Minh Truong, Tran Minh Chau Ph |
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study. Journal of the Formosan Medical Association = Taiwan yi zhi 2024 12 . Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, Kuan-Yu Chen, Tzu-Hsiu Tsai, Chia-Lin Hsu, Kang-Yi Su, Yih-Leong Chang, Chen-Tu Wu, Chia-Chi Hsu, Yi-Nan Liu, Guan-Ru Peng, Almanzo Aeterna Kangartaputra, Shu-Han Yu, Bin-Chi Liao, Wei-Hsun Hsu, Jih-Hsiang Lee, Chia-Chi Lin, Jin-Yuan Shih, James Chih-Hsin Yang, Chong-Jen |
Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Parikh Kaushal, Xiuning Le, Giovanni Ciriello, Alfredo Add |
Elevated Serum Direct Bilirubin and Smoking Status Are Prognostic Factors for EGFR-Mutated Non-Small Cell Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy. Cancers 2024 12 16 (23): . Jingyuan Zhang, Yinwang Zhang, Yuqiong Lei, Qi Zheng, Xiaohua Gu, Zeyu Liu, Yongle Xu, Cheng Zhong, Shan Shan, Tao R |
Prognostic impact of EGFR mutations in T1-4N0M0 lung adenocarcinoma: analyses focus on imaging and pathological features. Journal of thoracic disease 2024 12 16 (11): 7244-7256. Jing-Yu Chen, Ying Zhu, Bao-Cong Liu, Hui-Yun Ma, Lu-Jie Li, Mei-Cheng Chen, Shu-Chang Zhou, Xiang-Min Li, Jian-Ting Long, Qiong |
Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy. Cancer management and research 2024 12 16 1759-1773. Sai Te Er Nu Er Lan, Bo Yu, Yan Yang, Yanli Shen, Bing Xu, Yiyi Zhan, Chunling L |
Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis. Cancer genetics 2024 12 290-291 36-43. Haiqiao Pan, Hongbin Zhang, Yongqian Zhang, Xiaojing Chen, Zhai Liu, Yajing Wu, Na Bai, Yan Shi, Min Zhao, Lingling Z |
Public assistance and survival equality in patients with EGFR mutation-positive lung cancer. Japanese journal of clinical oncology 2024 12 . Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, Takahiro Mase, Yoshiaki Fujimura, Maki Hayashi, Megu Ohtaki, Keiko Otani, Makoto Hibino, Shigeto Horiuchi, Tomoya Fukui, Ryuta Fukai, Yusuke Chihara, Akihiko Iwase, Noriko Yamada, Yukihiro Tamura, Hiromasa Harada, Asuka Tsuya, Takafumi Okabe, Masahiro Fukuoka, Hironobu Mina |
Prognostic impact of targetable driver alterations in resected early-stage lung cancer. Translational lung cancer research 2024 12 13 (11): 3096-3105. Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J Jost, Jörg Lindenmann, Paul Swatek, Nikolaus John, Teresa John, Robert Wurm, Martin Zacharias, Florian Posch, Maximilian J Hochmair, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Lena Horvath, Gabriele Gamerith, Dominik Wolf, Florian Augustin, Luka Brc |
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer. Translational lung cancer research 2024 12 13 (11): 3067-3082. Nanao Terada, Hayato Koba, Shigeki Nanjo, Hideharu Kimura, Akihiro Nishiyama, Taro Yoneda, Takayuki Takeda, Hiroki Shirasaki, Koichi Nishi, Takashi Sone, Tadaaki Yamada, Koichi Takayama, Kazuhiko Shibata, Hiroki Matsuoka, Toshiyuki Kita, Kazuhiro Nagata, Yuichi Tambo, Noriyuki Ohkura, Johsuke Hara, Kazuo Kasahara, Shinji Kohsaka, Hiroyuki Mano, Seiji Ya |
EGFR exon 20 insertion mutation and MET exon 14 skipping mutation in non-small cell lung cancer: a scoping review in the Chinese population. Translational lung cancer research 2024 12 13 (11): 3224-3240. Xiao-Rong Yang, Si-Min Zhong, Zhen-Yi Jin, X?n Gào, Ying Wu, Qing Zhou, Yang-Qiu Li, Si-Yang Maggie Liu, Yi-Long |
Clinical Response to Osimertinib in a Non-Small-Cell Lung Cancer Patient With EGFR L833V/H835L Mutations: A Case Report. Journal of investigative medicine high impact case reports 2024 11 12 23247096241300929. Jowan Al-Nusair, Reesha Bodiwala, Kemnasom Nwanwene, Mahmoud Abdallah, Mohamed Alshal, Toni Paciol |
Clinical and Molecular Features of Malignant Pleural Effusion in Non-Small Cell Lung Cancer (NSCLC) of a Caucasian Population. Medicina (Kaunas, Lithuania) 2024 11 60 (11): . Irene Lojo-Rodríguez, Maribel Botana-Rial, Almudena González-Montaos, Virginia Leiro-Fernández, Ana González-Piñeiro, Cristina Ramos-Hernández, Alberto Fernández-Vill |
- Page last reviewed:Feb 1, 2024
- Content source: